tiprankstipranks
AtriCure assumed with an Overweight at JPMorgan
PremiumThe FlyAtriCure assumed with an Overweight at JPMorgan
2M ago
AtriCure price target raised to $61 from $53 at Canaccord
Premium
The Fly
AtriCure price target raised to $61 from $53 at Canaccord
2M ago
AtriCure price target raised to $36 from $32 at Oppenheimer
Premium
The Fly
AtriCure price target raised to $36 from $32 at Oppenheimer
3M ago
AtriCure narrows FY24 EPS view to (80c)-(74c) from (82c)-(74c), consensus (79c)
PremiumThe FlyAtriCure narrows FY24 EPS view to (80c)-(74c) from (82c)-(74c), consensus (79c)
3M ago
ATRC Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
ATRC Upcoming Earnings Report: What to Expect?
3M ago
AtriCure receives CE-Mark for the EnCompass Clamp
Premium
The Fly
AtriCure receives CE-Mark for the EnCompass Clamp
4M ago
AtriCure price target lowered to $40 from $65 at Piper Sandler
PremiumThe FlyAtriCure price target lowered to $40 from $65 at Piper Sandler
6M ago
AtriCure sees FY24 EPS (82c) to (74c), consensus (78c)
Premium
The Fly
AtriCure sees FY24 EPS (82c) to (74c), consensus (78c)
6M ago
AtriCure reports Q2 EPS (17c), consensus (17c)
Premium
The Fly
AtriCure reports Q2 EPS (17c), consensus (17c)
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100